Navigation Links
Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
Date:5/16/2012

ajority of the cases are considered allergic asthma, for which there is no known cure.  Acute and severe episodes of the disease make up approximately two million Emergency Room visits each year, accounting for 25% of all visits.

R343, Inhaled SYK Inhibitor
In patients with allergic asthma, allergens, such as pollen, trigger the production of immunoglobulin E (IgE) antibodies, which then bind to mast cells (the body's defense system gatekeepers in the lung) and spark a cascade of intracellular signals to mount an immune response resulting in swelling and inflammation of the airways. SYK is a protein tyrosine kinase that plays a pivotal role in IgE receptor signaling in mast cells. Rigel's R343 is designed to bind to the SYK in mast cells and to interrupt the signal from the IgE receptors. R343's ability to inhibit SYK potentially prevents or stops the immune response to the allergen and may be effective in the short and long-term control of allergic asthma.

Rigel expects to initiate a multi-center, multiple-dose, and placebo-controlled study with R343 in approximately 270 asthma patients this summer.

To view Rigel's R343 Asthma Animation, please go to: http://www.rigel.com/rigel/aa.

R256, Inhaled IL13 Signaling /JAK Inhibitor
In patients with severe or chronic asthma, the cells lining the walls of the respiratory airways and lungs experience persistent inflammation and cellular remodeling resulting in scarring (pulmonary fibrosis) if left untreated.   Inhibition of JAK along the IL13 and IL4 signaling pathways, at the primary cellular level of the airways, may reduce or stop the inflammatory cascade associated with bronchospasms, mucus overproduction, cell wall thickening and other symptoms of chronic lung obstruction.  Rigel has conducted preclinical studies with R256 in a variety of models and expects to initiate preclinical development leading to an I
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
2. Rigels R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
3. Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
4. Rigels R788 Shows Preclinical Activity in Type 1 Diabetes Model
5. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
6. Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
7. Rigels R788 Phase 2a Results Published in Arthritis and Rheumatism
8. Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
9. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
10. Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
11. Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... KALAMAZOO, Mich. , June 29, 2015 /PRNewswire/ ... Association and American Stroke Association give hope for ... patients who experience an acute ischemic stroke each ... of the key products used in the clinical ... The new AHA/ASA guidelines strongly recommend endovascular ...
(Date:6/29/2015)... , June 29, 2015 ... positive preliminary results from its BVX-006 Phase II clinical ... vaccine. In this trial, M-001 was injected intramuscularly to ... by an administration of the 2014/15 season trivalent influenza ... be safe and well tolerated and induced humoral immune ...
(Date:6/29/2015)... Calif. , June 29, 2015  Isis Pharmaceuticals, ... has been added to the Russell 1000 Index, effective ... performance of the large-cap segment of the U.S. equity ... Index and includes approximately 1000 of the largest securities ... current index membership. "We are pleased to ...
Breaking Medicine Technology:New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3
... JERUSALEM, Oct. 13, 2011 IDenta Corp. (OTC: IDTA) CEO ... Shoham stated, "We are succeeding in making sales in many ... products. We have received an order for 2000 ... http://www.gksolutions.com.au/ In the past several ...
... Association for Homecare urges the Joint Select Committee on ... cuts that will restrict access to home medical ... Over the years, homecare has broadened health care access ... the health care system by keeping seniors and people ...
Cached Medicine Technology:International Drug & Explosives Detection Company IDenta Corp. Receives Order From Australia 2American Association for Homecare Calls on Joint Deficit Committee in Congress to Preserve Homecare Access for Millions of Americans 2
(Date:6/29/2015)... ... June 29, 2015 , ... ... contractors, nonprofits, independent schools, and other growing businesses across the United States, has ... Value Added Resellers for the fifth consecutive year. , Based on company revenue ...
(Date:6/29/2015)... (PRWEB) , ... June 29, 2015 , ... ... have developed a new approach to build nearly complete genomes by combining high-throughput ... of genomic variation, critically important for their association with human disease, but previously ...
(Date:6/29/2015)... ... June 29, 2015 , ... San Fernando Valley skin doctor ... sagging skin. Ulthera is a special treatment that offers a way to firm sagging ... gently stimulate collagen production. Ulthera is highly targeted and precise to help reduce treatment ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... and Chemical Technology of The Hong Kong Polytechnic University (PolyU) has developed a ... Authentication of edible oils has been a long-term issue in food safety, and ...
(Date:6/29/2015)... ... June 29, 2015 , ... Minneapolis Saint Paul ... Cities area, provides money-saving tactics during a season of increased water and air ... water conservation and other economical practices. , According to the U.S. Department ...
Breaking Medicine News(10 mins):Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 2Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 4Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 2Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 3Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2Health News:Save Energy: MSP Plumbing, Heating & Air Endorses Efficiency 2Health News:Save Energy: MSP Plumbing, Heating & Air Endorses Efficiency 3
... reservations on one side and on the other side increasing ... not suffer is the UPA Government’s please-all formula//. ... 27 per cent of the seats in Central educational institutions ... 2007. Simultaneously, it has been decided to increase the number ...
... A group of autoimmune diseases, named Juvenile rheumatoid ... which inversely affect health-related quality of life// , ... adults – study finds. But nothing regarding children ... Research journal published a study in the June ...
... entrance test tomorrow to join the MBBS course at ... Education and Research (JIPMER) here. // ,These ... in Pondicherry, New Delhi, Chennai, Hyderabad, Kolkata and Thiruvananthapuram ... the Dean the institute Dr K S Reddy said ...
... Indian Medical Association today said that private doctors have announced ... for OBCs // , and have decided to close their ... Dental Association, Rajkot, have also extended its support to anti-quota ... release here., ,At least 70 medical students and junior ...
... A study by Florida State University researchers said, ‘Self-critical adult ... they are grown up in a verbally// abused environment in ... times more likely to have symptoms of depression and anxiety ... on 5,614 people aged between 15 and 54, conducted by ...
... planning to bifurcate the Health and Family Welfare Department ... This step is thought to allow for streamlined health ... R Ashok said that the step was being taken ... system. Initially the government will ask 23 doctors who ...
Cached Medicine News:Health News:The Government’s Balancing Act on Reservatio 2Health News:The Government’s Balancing Act on Reservatio 3Health News:Socioeconomic Status Plays A Role In Juvenile Rheumatoid Arthritis 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: